Cargando…
Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242142/ https://www.ncbi.nlm.nih.gov/pubmed/34211313 http://dx.doi.org/10.2147/PHMT.S314259 |
_version_ | 1783715567405891584 |
---|---|
author | Tucho, Walelign Atomsa Tekelehaimanot, Aderajew Nigusse Habte, Mahilet Berhanu |
author_facet | Tucho, Walelign Atomsa Tekelehaimanot, Aderajew Nigusse Habte, Mahilet Berhanu |
author_sort | Tucho, Walelign Atomsa |
collection | PubMed |
description | BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of disclosure and associated factors among a cohort of HIV-infected children in southwest Ethiopia. METHODS: A facility-based cross-sectional study design was employed among caregivers of HIV-positive children aged 6–15 in Bench sheko and West Omo zone Southwest Ethiopia, from March 1 to April 20, 2020. Study participants were included using a consecutive sampling technique. Data were collected using a pretested interviewer administered questionnaire and checklist. A multivariable logistic regressions model was used to identify independent predictors of disclosure. The significance of association was declared by AOR at 95% confidence and a p-value <0.05. RESULTS: A total of 327 participants were involved in the study yielding a 95% response rate. The prevalence of HIV-positive status disclosure was 45.6% (95% CI=41.01–51.02). Caregiver secondary education and above (AOR=3.16, 95% CI=1.07–9.34), caregiver discussed about disclosure with health professionals (AOR= 9.56, 95% CI=4.88–18.74), child age 10–15 year old (AOR=3.64, 95% CI=1.64–8.08), duration on ART >5 years (AOR=5.08, 95% CI=1.57–16.37), treatment follow-up at hospital (AOR=2.23, 95% CI=1.27–5.01) and having treatment support for Children (AOR=3.84, 95% CI=1.88–7.85) were independent predictors of HIV-positive status disclosure. CONCLUSION: Disclosure of HIV status to children is low. Caregivers educational status, caregivers discussion with health professional, older child, duration on ART of more than 5 year, getting treatment service from hospital, and having a treatment support group are factors that enable disclosure. Therefore, concerted efforts based on the findings of this study will be required to improve the disclosure status among HIV-positive children. |
format | Online Article Text |
id | pubmed-8242142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82421422021-06-30 Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia Tucho, Walelign Atomsa Tekelehaimanot, Aderajew Nigusse Habte, Mahilet Berhanu Pediatric Health Med Ther Original Research BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of disclosure and associated factors among a cohort of HIV-infected children in southwest Ethiopia. METHODS: A facility-based cross-sectional study design was employed among caregivers of HIV-positive children aged 6–15 in Bench sheko and West Omo zone Southwest Ethiopia, from March 1 to April 20, 2020. Study participants were included using a consecutive sampling technique. Data were collected using a pretested interviewer administered questionnaire and checklist. A multivariable logistic regressions model was used to identify independent predictors of disclosure. The significance of association was declared by AOR at 95% confidence and a p-value <0.05. RESULTS: A total of 327 participants were involved in the study yielding a 95% response rate. The prevalence of HIV-positive status disclosure was 45.6% (95% CI=41.01–51.02). Caregiver secondary education and above (AOR=3.16, 95% CI=1.07–9.34), caregiver discussed about disclosure with health professionals (AOR= 9.56, 95% CI=4.88–18.74), child age 10–15 year old (AOR=3.64, 95% CI=1.64–8.08), duration on ART >5 years (AOR=5.08, 95% CI=1.57–16.37), treatment follow-up at hospital (AOR=2.23, 95% CI=1.27–5.01) and having treatment support for Children (AOR=3.84, 95% CI=1.88–7.85) were independent predictors of HIV-positive status disclosure. CONCLUSION: Disclosure of HIV status to children is low. Caregivers educational status, caregivers discussion with health professional, older child, duration on ART of more than 5 year, getting treatment service from hospital, and having a treatment support group are factors that enable disclosure. Therefore, concerted efforts based on the findings of this study will be required to improve the disclosure status among HIV-positive children. Dove 2021-06-25 /pmc/articles/PMC8242142/ /pubmed/34211313 http://dx.doi.org/10.2147/PHMT.S314259 Text en © 2021 Tucho et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Tucho, Walelign Atomsa Tekelehaimanot, Aderajew Nigusse Habte, Mahilet Berhanu Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title | Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title_full | Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title_fullStr | Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title_full_unstemmed | Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title_short | Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia |
title_sort | disclosure status and associated factors among children on antiretroviral therapy in ethiopia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242142/ https://www.ncbi.nlm.nih.gov/pubmed/34211313 http://dx.doi.org/10.2147/PHMT.S314259 |
work_keys_str_mv | AT tuchowalelignatomsa disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia AT tekelehaimanotaderajewnigusse disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia AT habtemahiletberhanu disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia |